171 related articles for article (PubMed ID: 27323822)
1. Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways.
Zins K; Schäfer R; Paulus P; Dobler S; Fakhari N; Sioud M; Aharinejad S; Abraham D
Oncotarget; 2016 Jul; 7(29):46187-46202. PubMed ID: 27323822
[TBL] [Abstract][Full Text] [Related]
2. A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.
Gujral TS; Chan M; Peshkin L; Sorger PK; Kirschner MW; MacBeath G
Cell; 2014 Nov; 159(4):844-56. PubMed ID: 25417160
[TBL] [Abstract][Full Text] [Related]
3. FZD2 regulates limb development by mediating β-catenin-dependent and -independent Wnt signaling pathways.
Zhu X; Xu M; Leu NA; Morrisey EE; Millar SE
Dis Model Mech; 2023 Mar; 16(3):. PubMed ID: 36867021
[TBL] [Abstract][Full Text] [Related]
4. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.
Vieira GC; Chockalingam S; Melegh Z; Greenhough A; Malik S; Szemes M; Park JH; Kaidi A; Zhou L; Catchpoole D; Morgan R; Bates DO; Gabb PD; Malik K
Oncotarget; 2015 Nov; 6(37):40053-67. PubMed ID: 26517508
[TBL] [Abstract][Full Text] [Related]
5. NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth.
Tringali C; Cirillo F; Lamorte G; Papini N; Anastasia L; Lupo B; Silvestri I; Tettamanti G; Venerando B
Int J Cancer; 2012 Oct; 131(8):1768-78. PubMed ID: 22287118
[TBL] [Abstract][Full Text] [Related]
6. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
7. Lens regeneration from the cornea requires suppression of Wnt/β-catenin signaling.
Hamilton PW; Sun Y; Henry JJ
Exp Eye Res; 2016 Apr; 145():206-215. PubMed ID: 26778749
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Frizzled-2-mediated Wnt/Ca²⁺ signaling significantly attenuates intracellular calcium accumulation in vitro and in a rat model of traumatic brain injury.
Niu LJ; Xu RX; Zhang P; Du MX; Jiang XD
Neuroscience; 2012 Jun; 213():19-28. PubMed ID: 22521824
[TBL] [Abstract][Full Text] [Related]
9. Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
Liu X; Mazanek P; Dam V; Wang Q; Zhao H; Guo R; Jagannathan J; Cnaan A; Maris JM; Hogarty MD
Oncogene; 2008 Feb; 27(10):1478-88. PubMed ID: 17724465
[TBL] [Abstract][Full Text] [Related]
10. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
[TBL] [Abstract][Full Text] [Related]
11. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT.
Bisson JA; Mills B; Paul Helt JC; Zwaka TP; Cohen ED
Dev Biol; 2015 Feb; 398(1):80-96. PubMed ID: 25482987
[TBL] [Abstract][Full Text] [Related]
12. WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration.
Yang J; Cusimano A; Monga JK; Preziosi ME; Pullara F; Calero G; Lang R; Yamaguchi TP; Nejak-Bowen KN; Monga SP
Am J Pathol; 2015 Aug; 185(8):2194-205. PubMed ID: 26100214
[TBL] [Abstract][Full Text] [Related]
13. A review of 1α,25(OH)2D3 dependent Pdia3 receptor complex components in Wnt5a non-canonical pathway signaling.
Doroudi M; Olivares-Navarrete R; Boyan BD; Schwartz Z
J Steroid Biochem Mol Biol; 2015 Aug; 152():84-8. PubMed ID: 25845934
[TBL] [Abstract][Full Text] [Related]
14. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
15. Wnt pathway markers in molecular subgroups of glioblastoma.
Tompa M; Nagy A; Komoly S; Kalman B
Brain Res; 2019 Sep; 1718():114-125. PubMed ID: 31075260
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a signaling controls cytokinesis by correctly positioning ESCRT-III at the midbody.
Fumoto K; Kikuchi K; Gon H; Kikuchi A
J Cell Sci; 2012 Oct; 125(Pt 20):4822-32. PubMed ID: 22825874
[TBL] [Abstract][Full Text] [Related]
18. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
Leung CO; Mak WN; Kai AK; Chan KS; Lee TK; Ng IO; Lo RC
Oncotarget; 2016 May; 7(20):29371-86. PubMed ID: 27105493
[TBL] [Abstract][Full Text] [Related]
19. Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling.
Sakane H; Yamamoto H; Matsumoto S; Sato A; Kikuchi A
J Cell Sci; 2012 Jan; 125(Pt 2):449-60. PubMed ID: 22302992
[TBL] [Abstract][Full Text] [Related]
20. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
